38 studies found for:    "Microscopic polyangiitis"
Show Display Options
Rank Status Study
21 Completed Vasculitis Illness Perception (VIP) Study
Conditions: Wegener Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu's Arteritis;   Henoch-Schoenlein Purpura;   Behcet's Disease;   CNS Vasculitis
Intervention:
22 Unknown  Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
Conditions: Wegener's Granulomatosis;   Churg-Strauss Syndrome;   Microscopic Polyangiitis;   Polyarteritis Nodosa
Interventions: Drug: Methotrexate;   Drug: Cyclophosphamide
23 Recruiting Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Interventions: Drug: Glucocorticoids;   Drug: Rituximab
24 Completed Educational Needs of Patients With Systemic Vasculitis
Conditions: Behcet's Disease;   Churg-Strauss Syndrome;   Vasculitis, Central Nervous System;   Giant Cell Arteritis;   Wegener Granulomatosis;   Henoch-Schoenlein Purpura;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
25 Terminated Plasma Exchange for Renal Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis
Interventions: Procedure: Plasma exchange;   Drug: Intravenous methyl prednisolone;   Drug: Methyl prednisolone
26 Enrolling by invitation VCRC Patient Contact Registry Patient-Reported Data Validation Study
Conditions: Behcet's Disease;   Churg-Strauss Syndrome;   Giant Cell Arteritis;   Wegener Granulomatosis;   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
27 Enrolling by invitation Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Intervention: Other: Observational
28 Completed Reproductive Health in Men and Women With Vasculitis
Conditions: Giant Cell Arteritis;   Takayasu's Arteritis;   Polyarteritis Nodosa;   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Behcet's Disease;   Kawasaki Disease;   Henoch-schoenlein Purpura;   Vasculitis, Central Nervous System;   Drug-induced Necrotizing Vasculitis
Intervention:
29 Completed Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
Conditions: Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Polyarteritis Nodosa
Interventions: Drug: prednisone, methylprednisolone,cyclophosphamides;   Drug: Cyclophosphamide, Azathioprine,prednisone,methylprednisolone;   Drug: Mycophenolate mofetil,methotrexate
30 Active, not recruiting Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis NODOSA or Churg Strauss Syndrome
Conditions: MPA;   FFS=0;   At Diagnosis or Within the First 15 Days Following;   Initiation of Corticosteroids.
Interventions: Drug: corticosteroid and azathioprine;   Drug: corticosteroid and placebo
31 Not yet recruiting A Study Evaluating the Safety and Efficacy of Ristova (Rituximab) in Combination With Glucocorticoids in Patients With Wegener's Granulomatosis or Microscopic Polyangitis
Condition: Wegener's Granulomatosis, Microscopic Polyangiitis
Interventions: Drug: rituximab [Ristova];   Drug: methylprednisolone;   Drug: prednisone
32 Terminated IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis
Conditions: ANCA Associated Systemic Vasculitis Including Wegener’s;   Granulomatosis and Microscopic Polyangiitis and;   Renal Limited Vasculitis
Interventions: Drug: Cyclophosphamide;   Drug: Mycophenolate mofetil;   Drug: Azathioprine;   Drug: Prednisone (and methylprednisolone)
33 Unknown  Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
Conditions: Wegener's Granulomatosis;   Vasculitis
Interventions: Drug: mycophenolate mofetil;   Drug: cyclophosphamide
34 Recruiting Belimumab in Remission of VASculitis
Condition: Vasculitis
Interventions: Biological: Placebo;   Biological: Belimumab 10 mg/kg;   Drug: Azathioprine
35 Terminated Intravenous Immunoglobulin After Relapse in Vasculitis
Conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid;   and Immunosuppressant Therapies or After One Year;   Post Treatment.
Intervention: Drug: Intravenous immunoglobulins (human immunoglobulins G)
36 Terminated Abatacept in ANCA Associated Vasculitis
Condition: ANCA-associated Vasculitis
Intervention: Drug: Abatacept (Orencia)
37 Recruiting Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
Condition: Granulomatosis With Polyangiitis
Interventions: Other: Blood samples and clinical data;   Other: Blood sample
38 Unknown  WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides
Condition: Systemic Wegener's Granulomatosis
Interventions: Drug: Azathioprine: 2 mg/kg/day;   Drug: methotrexate 0.3 mg/kg/week, to a maximum and optimal dose of 25 mg/week

Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page
Indicates status has not been verified in more than two years